vedolizumab,infliximab
janssen,takeda
['vedolizumab', 'vedo', ' vedo', 'infliximab']
#ddw2023 infliximab was associated with fewer discontinuations for lack of efficacy than vedolizumab during the maintenance phase of #ulcerativecolitis treatment, an updated meta-analysis of randomized clinical trials reveals. 
Medscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.